Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for COLL

Stock NameCollegium Pharmaceutical Inc
TickerCOLL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS19459J1043
LEI54930049FXZMTLW8D496

Show aggregate COLL holdings

News associated with COLL

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at HC Wainwright
HC Wainwright upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) to a strong-buy rating in a report released on Monday morning, MarketBeat Ratings reports. The firm currently has $44.00 target price on the specialty pharmaceutical company’s stock. COLL has been the subject of several other reports. Wall Street Zen upgraded Collegium Pharmaceutical from a […] - 2025-08-14 03:00:52
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Wall Street Zen
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday. Separately, Piper Sandler reissued a “neutral” rating and set a $37.00 price objective (up previously from $36.00) on shares of Collegium Pharmaceutical […] - 2025-08-11 04:33:01
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,671 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,895 […] - 2025-07-29 05:22:58
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Victory Capital Management Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 10.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,713 shares of the specialty pharmaceutical company’s stock after selling 60,823 shares during the quarter. Victory Capital […] - 2025-07-24 04:53:18
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp decreased its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 242,261 shares of the specialty pharmaceutical company’s stock after selling 10,426 shares during the period. Bank of New York Mellon Corp’s holdings in Collegium Pharmaceutical were […] - 2025-07-23 04:42:46
Collegium Pharmaceutical (NASDAQ:COLL) to Repurchase $150.00 million in Outstanding Stock
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) announced that its Board of Directors has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in outstanding shares. This buyback authorization allows the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market […] - 2025-07-09 02:16:45
Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL
In trading on Monday, shares of Collegium Pharmaceutical Inc (Symbol: COLL) crossed above their 200 day moving average of $31.15, changing hands as high as $31.83 per share. Collegium Pharmaceutical Inc shares are currently trading up about 4.2% on the day. The chart below sho - 2025-07-07 12:54:17
Principal Financial Group Inc. Sells 71,695 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Principal Financial Group Inc. decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,573,356 shares of the specialty pharmaceutical company’s stock after selling 71,695 shares during the quarter. Principal […] - 2025-07-07 05:54:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,820 shares of the specialty pharmaceutical company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-07-04 05:19:14
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ritholtz Wealth Management
Ritholtz Wealth Management lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 32,108 shares of the specialty pharmaceutical company’s stock after selling 1,676 shares during the quarter. Ritholtz Wealth Management’s holdings in Collegium Pharmaceutical were worth $958,000 as of its most […] - 2025-06-18 05:56:50
Exchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Exchange Traded Concepts LLC cut its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,426 shares of the specialty pharmaceutical company’s stock after selling 12,669 shares during […] - 2025-06-18 05:18:59
Farther Finance Advisors LLC Raises Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Farther Finance Advisors LLC boosted its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,091 shares of the specialty pharmaceutical company’s stock after acquiring an additional 477 shares during the period. Farther Finance Advisors LLC’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-18 04:30:54
California State Teachers Retirement System Has $862,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
California State Teachers Retirement System reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,093 shares of the specialty pharmaceutical company’s stock after selling 856 shares during the period. California State Teachers Retirement System’s holdings in Collegium Pharmaceutical were […] - 2025-06-11 05:04:51
Wellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Wellington Management Group LLP reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 88,591 shares of the specialty pharmaceutical company’s stock after selling 26,049 shares during the period. Wellington Management Group […] - 2025-06-06 05:04:54
Bank of America Corp DE Trims Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Bank of America Corp DE decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 29.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 86,096 shares of the specialty pharmaceutical company’s stock after selling 36,093 shares during the period. Bank of America Corp DE’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-02 04:38:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by ProShare Advisors LLC
ProShare Advisors LLC boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 28.8% in the 4th quarter, Holdings Channel reports. The fund owned 11,196 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,506 shares during the quarter. ProShare Advisors LLC’s holdings in Collegium Pharmaceutical were worth $321,000 […] - 2025-05-30 05:06:52
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.80 Average Price Target from Brokerages
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-05-21 03:14:51
Voya Investment Management LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Voya Investment Management LLC lessened its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,923 shares of the specialty pharmaceutical company’s stock after selling 789 shares during the period. Voya […] - 2025-05-13 04:32:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stake Reduced by Hsbc Holdings PLC
Hsbc Holdings PLC decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,879 shares of the specialty pharmaceutical company’s stock after selling 576 shares during the period. Hsbc Holdings PLC’s holdings in Collegium Pharmaceutical were worth $483,000 at the end […] - 2025-05-07 05:00:51
Barclays PLC Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Barclays PLC increased its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,754 shares of the specialty pharmaceutical company’s stock after purchasing an additional 4,702 shares during the […] - 2025-05-01 05:14:59
Raymond James Financial Inc. Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Raymond James Financial Inc. bought a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 84,883 shares of the specialty pharmaceutical company’s stock, valued at approximately $2,432,000. Other hedge funds and […] - 2025-04-30 05:10:55
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Legal & General Group Plc
Legal & General Group Plc lessened its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 91,309 shares of the specialty pharmaceutical company’s stock after selling 1,084 shares during the period. Legal & General Group Plc’s holdings in Collegium Pharmaceutical were […] - 2025-04-24 06:31:01
Russell Investments Group Ltd. Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Russell Investments Group Ltd. reduced its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,649 shares of the specialty pharmaceutical company’s stock after selling 6,223 shares […] - 2025-04-24 04:48:48
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
JPMorgan Chase & Co. lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,691 shares of the specialty pharmaceutical company’s stock after selling 194,513 shares during the […] - 2025-04-24 04:16:59
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a […] - 2025-04-21 02:22:45
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Invesco Ltd.
Invesco Ltd. grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 19.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,775,760 shares of the specialty pharmaceutical company’s stock after acquiring an additional 289,335 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-16 04:47:00
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently weighed in on COLL. Needham & Company LLC reaffirmed a “buy” rating and issued a $46.00 target price on […] - 2025-04-14 02:58:57
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Vanguard Group Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,282,666 shares of the specialty pharmaceutical company’s stock after selling 63,876 shares during the period. Vanguard Group Inc. […] - 2025-04-11 06:16:58
Corebridge Financial Inc. Sells 1,595 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Corebridge Financial Inc. lowered its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 17,084 shares of the specialty pharmaceutical company’s stock after selling 1,595 shares during the period. Corebridge Financial Inc.’s holdings in Collegium Pharmaceutical were worth $489,000 as of its […] - 2025-04-09 04:38:48
American Century Companies Inc. Has $2.45 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,466 shares of the specialty pharmaceutical company’s stock after selling 19,447 […] - 2025-04-08 05:04:48

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) COLL holdings

DateNumber of COLL Shares HeldBase Market Value of COLL SharesLocal Market Value of COLL SharesChange in COLL Shares HeldChange in COLL Base ValueCurrent Price per COLL Share HeldPrevious Price per COLL Share Held
2025-11-11 (Tuesday)20,223USD 906,799COLL holding increased by 26492USD 906,7990USD 26,492 USD 44.84 USD 43.53
2025-11-10 (Monday)20,223COLL holding increased by 52USD 880,307COLL holding increased by 27074USD 880,30752USD 27,074 USD 43.53 USD 42.3
2025-11-07 (Friday)20,171USD 853,233COLL holding increased by 33080USD 853,2330USD 33,080 USD 42.3 USD 40.66
2025-11-06 (Thursday)20,171COLL holding increased by 52USD 820,153COLL holding increased by 98887USD 820,15352USD 98,887 USD 40.66 USD 35.85
2025-11-05 (Wednesday)20,119USD 721,266COLL holding increased by 1811USD 721,2660USD 1,811 USD 35.85 USD 35.76
2025-11-04 (Tuesday)20,119COLL holding increased by 52USD 719,455COLL holding decreased by -4964USD 719,45552USD -4,964 USD 35.76 USD 36.1
2025-11-03 (Monday)20,067USD 724,419COLL holding increased by 2007USD 724,4190USD 2,007 USD 36.1 USD 36
2025-10-31 (Friday)20,067USD 722,412COLL holding increased by 7023USD 722,4120USD 7,023 USD 36 USD 35.65
2025-10-30 (Thursday)20,067COLL holding increased by 260USD 715,389COLL holding increased by 25907USD 715,389260USD 25,907 USD 35.65 USD 34.81
2025-10-29 (Wednesday)19,807COLL holding increased by 104USD 689,482COLL holding decreased by -8201USD 689,482104USD -8,201 USD 34.81 USD 35.41
2025-10-28 (Tuesday)19,703USD 697,683COLL holding increased by 11723USD 697,6830USD 11,723 USD 35.41 USD 34.815
2025-10-27 (Monday)19,703USD 685,960COLL holding decreased by -9556USD 685,9600USD -9,556 USD 34.815 USD 35.3
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COLL by Blackrock for IE00BYXG2H39

Show aggregate share trades of COLL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY5243.68041.980 42.150USD 2,192 31.19
2025-11-06BUY5241.81039.080 39.353USD 2,046 31.09
2025-11-04BUY5236.54035.620 35.712USD 1,857 31.04
2025-10-30BUY26035.76033.890 34.077USD 8,860 30.96
2025-10-29BUY10434.81035.900 35.791USD 3,722 30.94
2025-10-22SELL-20835.71035.915 35.895USD -7,466 30.82 Loss of -1,055 on sale
2025-10-20BUY10434.85034.880 34.877USD 3,627 30.78
2025-10-17BUY26033.94034.070 34.057USD 8,855 30.76
2025-10-15BUY41632.88033.000 32.988USD 13,723 30.75
2025-10-03BUY36434.61035.150 35.096USD 12,775 30.72
2025-10-02BUY5234.28035.305 35.203USD 1,831 30.70
2025-09-30BUY10434.99035.535 35.481USD 3,690 30.65
2025-09-26BUY10434.41035.540 35.427USD 3,684 30.60
2025-09-25BUY10434.65036.290 36.126USD 3,757 30.58
2025-09-24SELL-1,44535.16035.450 35.421USD -51,183 30.55 Loss of -7,032 on sale
2025-09-18BUY5636.16036.260 36.250USD 2,030 30.52
2025-09-17BUY17135.54036.565 36.462USD 6,235 30.49
2025-08-20SELL-22438.37038.490 38.478USD -8,619 30.31 Loss of -1,830 on sale
2025-07-30BUY22430.70031.510 31.429USD 7,040 30.13
2025-07-17SELL-11232.26032.360 32.350USD -3,623 30.04 Loss of -259 on sale
2025-07-11SELL-44832.52033.010 32.961USD -14,767 29.98 Loss of -1,338 on sale
2025-07-07BUY16830.90031.990 31.881USD 5,356 29.92
2025-07-02BUY3,08030.51030.620 30.609USD 94,276 29.91
2025-06-20BUY89929.83029.970 29.956USD 26,930 29.91
2025-06-11BUY10829.69030.590 30.500USD 3,294 29.93
2025-06-10BUY10830.37030.930 30.874USD 3,334 29.93
2025-06-04SELL-5429.40029.720 29.688USD -1,603 29.93 Profit of 13 on sale
2025-04-23BUY5325.99027.477 27.328USD 1,448 30.39
2025-04-10SELL-42424.67025.990 25.858USD -10,964 30.77 Profit of 2,083 on sale
2025-04-08SELL-5325.41028.000 27.741USD -1,470 30.88 Profit of 167 on sale
2025-04-07SELL-5327.38028.365 28.266USD -1,498 30.92 Profit of 141 on sale
2025-04-04SELL-26528.14028.340 28.320USD -7,505 30.96 Profit of 699 on sale
2025-04-01BUY97429.39030.525 30.411USD 29,621 30.99
2025-03-31SELL-15329.85030.200 30.165USD -4,615 31.00 Profit of 128 on sale
2025-03-14SELL-81629.46030.010 29.955USD -24,443 31.17 Profit of 995 on sale
2025-03-07SELL-10228.91030.010 29.900USD -3,050 31.30 Profit of 143 on sale
2025-03-04SELL-5128.04028.610 28.553USD -1,456 31.42 Profit of 146 on sale
2025-02-25BUY10228.82029.400 29.342USD 2,993 31.67
2025-02-19SELL-5129.91030.385 30.338USD -1,547 31.83 Profit of 76 on sale
2025-02-13BUY15330.98031.050 31.043USD 4,750 31.97
2025-02-12BUY5130.53031.530 31.430USD 1,603 32.00
2025-02-11BUY20431.58031.710 31.697USD 6,466 32.01
2024-12-30SELL-2,03628.61029.100 29.051USD -59,148 32.30 Profit of 6,625 on sale
2024-11-18SELL-84029.22029.780 29.724USD -24,968 34.32 Profit of 3,860 on sale
2024-11-08SELL-5632.16034.110 33.915USD -1,899 34.68 Profit of 43 on sale
2024-10-21SELL-5736.46038.515 38.309USD -2,184 0.00 Loss of -2,184 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COLL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1961,020088,70668.8%
2025-09-1841,541067,79461.3%
2025-09-1766,6180114,34758.3%
2025-09-16133,1610194,29868.5%
2025-09-15152,5510212,47871.8%
2025-09-1295,1360129,59873.4%
2025-09-11110,4230246,76444.7%
2025-09-1053,467099,00754.0%
2025-09-09109,5130233,49346.9%
2025-09-08206,3772311,09166.3%
2025-09-0578,1370150,74951.8%
2025-09-0464,0066,972105,81160.5%
2025-09-0363,5930122,60051.9%
2025-09-02101,0850159,73063.3%
2025-08-2946,4330126,23536.8%
2025-08-2851,923097,38753.3%
2025-08-2731,315075,37041.5%
2025-08-2640,9300153,66426.6%
2025-08-2556,6700122,83746.1%
2025-08-2235,5630123,46528.8%
2025-08-2136,265085,49942.4%
2025-08-2049,3641588,02056.1%
2025-08-1963,10950120,93652.2%
2025-08-1829,505092,25532.0%
2025-08-1520,662064,21132.2%
2025-08-1487,4240118,48173.8%
2025-08-1349,95814132,12337.8%
2025-08-1291,8240151,45160.6%
2025-08-11129,8833,211250,03551.9%
2025-08-0883,3940319,66326.1%
2025-08-07193,6760339,68757.0%
2025-08-0698,2330169,42058.0%
2025-08-0532,115070,96745.3%
2025-08-0436,300070,24351.7%
2025-08-01102,2750172,38059.3%
2025-07-3135,405066,55753.2%
2025-07-3021,992061,11236.0%
2025-07-2926,689072,67636.7%
2025-07-2822,692082,91327.4%
2025-07-2530,500069,12644.1%
2025-07-2426,485068,76738.5%
2025-07-2324,505067,62536.2%
2025-07-2241,4461,00484,38149.1%
2025-07-2132,627070,69346.2%
2025-07-1826,5881456,89546.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.